European Pensions & Investment News

Sections » PENSION FUND PROFILES » Novartis
  • A cure for Novartis’s fund

    Last year Novartis’s fund lost 7.3% of its investments, but still managed to pay 4% to its members. Sam Greene asks about its strategy

    More . . .  
Headlines from other FTB magazines
Contacts
Subscription
Privacy Policy
Terms and Conditions
Webmaster

Mailing address: Financial Times Ltd, Number One Southwark Bridge, London, SE1 9HL, United Kingdom

© The Financial Times Limited 2008